Rank | Gene Set | Z-score |
---|---|---|
1 | * phenol-containing compound catabolic process (GO:0019336) | 9.08264255 |
2 | behavioral response to nicotine (GO:0035095) | 7.89650072 |
3 | sympathetic nervous system development (GO:0048485) | 6.59431219 |
4 | NADH metabolic process (GO:0006734) | 6.01845205 |
5 | behavioral response to ethanol (GO:0048149) | 5.80986420 |
6 | epoxygenase P450 pathway (GO:0019373) | 5.58753265 |
7 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.38265408 |
8 | catechol-containing compound biosynthetic process (GO:0009713) | 5.24184231 |
9 | catecholamine biosynthetic process (GO:0042423) | 5.24184231 |
10 | alkaloid metabolic process (GO:0009820) | 5.08484156 |
11 | synaptic transmission, cholinergic (GO:0007271) | 4.82656187 |
12 | maternal behavior (GO:0042711) | 4.74983676 |
13 | dopamine biosynthetic process (GO:0042416) | 4.72435140 |
14 | response to water (GO:0009415) | 4.72138936 |
15 | norepinephrine metabolic process (GO:0042415) | 4.54668523 |
16 | lipoprotein transport (GO:0042953) | 4.53059571 |
17 | cellular glucuronidation (GO:0052695) | 4.45365787 |
18 | ethanol oxidation (GO:0006069) | 4.41088744 |
19 | urea metabolic process (GO:0019627) | 4.33443508 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.32315907 |
21 | urea cycle (GO:0000050) | 4.31617750 |
22 | uronic acid metabolic process (GO:0006063) | 4.27600854 |
23 | glucuronate metabolic process (GO:0019585) | 4.27600854 |
24 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.21718725 |
25 | parental behavior (GO:0060746) | 4.20767095 |
26 | catecholamine transport (GO:0051937) | 4.20134245 |
27 | diacylglycerol metabolic process (GO:0046339) | 4.20083009 |
28 | hormone catabolic process (GO:0042447) | 4.12139797 |
29 | * dopamine metabolic process (GO:0042417) | 4.08792968 |
30 | drug metabolic process (GO:0017144) | 4.00956075 |
31 | nitrogen cycle metabolic process (GO:0071941) | 3.97544624 |
32 | regulation of bile acid biosynthetic process (GO:0070857) | 3.96412426 |
33 | fructose metabolic process (GO:0006000) | 3.93675150 |
34 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.90736518 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 3.82167346 |
36 | negative regulation of microtubule polymerization (GO:0031115) | 3.78991605 |
37 | regulation of triglyceride catabolic process (GO:0010896) | 3.71854543 |
38 | transcytosis (GO:0045056) | 3.66032737 |
39 | intestinal absorption (GO:0050892) | 3.62573809 |
40 | enteric nervous system development (GO:0048484) | 3.60906477 |
41 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59760770 |
42 | bile acid and bile salt transport (GO:0015721) | 3.58312971 |
43 | response to pain (GO:0048265) | 3.58017489 |
44 | ethanol metabolic process (GO:0006067) | 3.55526009 |
45 | exogenous drug catabolic process (GO:0042738) | 3.51015997 |
46 | drug catabolic process (GO:0042737) | 3.48790127 |
47 | flavonoid metabolic process (GO:0009812) | 3.47831189 |
48 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.46675726 |
49 | endocrine process (GO:0050886) | 3.46675726 |
50 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.46675726 |
51 | neuromuscular synaptic transmission (GO:0007274) | 3.45189667 |
52 | cell migration in hindbrain (GO:0021535) | 3.43287963 |
53 | regulation of cholesterol homeostasis (GO:2000188) | 3.39656747 |
54 | triglyceride catabolic process (GO:0019433) | 3.38900250 |
55 | parturition (GO:0007567) | 3.34968208 |
56 | dopaminergic neuron differentiation (GO:0071542) | 3.32942442 |
57 | low-density lipoprotein particle clearance (GO:0034383) | 3.31569244 |
58 | proline transport (GO:0015824) | 3.29384615 |
59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27598087 |
60 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27598087 |
61 | actin filament depolymerization (GO:0030042) | 3.26459470 |
62 | bile acid metabolic process (GO:0008206) | 3.26306704 |
63 | oxaloacetate metabolic process (GO:0006107) | 3.24196657 |
64 | triglyceride biosynthetic process (GO:0019432) | 3.23990796 |
65 | phenol-containing compound biosynthetic process (GO:0046189) | 3.22720620 |
66 | renal system process involved in regulation of blood volume (GO:0001977) | 3.20977215 |
67 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.17226305 |
68 | neutral lipid biosynthetic process (GO:0046460) | 3.16593438 |
69 | acylglycerol biosynthetic process (GO:0046463) | 3.16593438 |
70 | positive regulation of lipid catabolic process (GO:0050996) | 3.15736812 |
71 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.14567295 |
72 | response to nerve growth factor (GO:1990089) | 3.14567295 |
73 | carnitine shuttle (GO:0006853) | 3.12083692 |
74 | neutral lipid catabolic process (GO:0046461) | 3.10703015 |
75 | acylglycerol catabolic process (GO:0046464) | 3.10703015 |
76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.08708334 |
77 | primary alcohol metabolic process (GO:0034308) | 3.08566400 |
78 | ATP synthesis coupled proton transport (GO:0015986) | 3.08547615 |
79 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.08547615 |
80 | ganglion development (GO:0061548) | 3.07632154 |
81 | adhesion of symbiont to host (GO:0044406) | 3.05629482 |
82 | regulation of cholesterol esterification (GO:0010872) | 3.05036001 |
83 | peptide hormone processing (GO:0016486) | 3.04968054 |
84 | fatty acid catabolic process (GO:0009062) | 3.02323800 |
85 | regulation of respiratory gaseous exchange (GO:0043576) | 3.00890374 |
86 | phospholipid efflux (GO:0033700) | 2.98544525 |
87 | regulation of systemic arterial blood pressure (GO:0003073) | 2.97483520 |
88 | fatty acid beta-oxidation (GO:0006635) | 2.96271536 |
89 | angiotensin maturation (GO:0002003) | 2.95411226 |
90 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.95222836 |
91 | omega-hydroxylase P450 pathway (GO:0097267) | 2.94079161 |
92 | fatty acid transmembrane transport (GO:1902001) | 2.93438428 |
93 | lipoprotein metabolic process (GO:0042157) | 2.93256130 |
94 | cGMP-mediated signaling (GO:0019934) | 2.93067526 |
95 | phospholipid homeostasis (GO:0055091) | 2.92114146 |
96 | plasma lipoprotein particle assembly (GO:0034377) | 2.90749550 |
97 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.89788039 |
98 | mating behavior (GO:0007617) | 2.89737269 |
99 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.89189248 |
100 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.89189248 |
101 | vocalization behavior (GO:0071625) | 2.88898662 |
102 | glycerol metabolic process (GO:0006071) | 2.88692621 |
103 | triglyceride metabolic process (GO:0006641) | 2.87227605 |
104 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.86852611 |
105 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85767118 |
106 | positive regulation of protein depolymerization (GO:1901881) | 2.84454501 |
107 | very long-chain fatty acid metabolic process (GO:0000038) | 2.83016272 |
108 | axon ensheathment in central nervous system (GO:0032291) | 2.82843033 |
109 | central nervous system myelination (GO:0022010) | 2.82843033 |
110 | amino-acid betaine transport (GO:0015838) | 2.82594575 |
111 | carnitine transport (GO:0015879) | 2.82594575 |
112 | regulation of cardioblast proliferation (GO:0003264) | 2.81468671 |
113 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.81468671 |
114 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.80865586 |
115 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.80865586 |
116 | alditol metabolic process (GO:0019400) | 2.78850756 |
117 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.78001488 |
118 | regulation of cholesterol metabolic process (GO:0090181) | 2.77715897 |
119 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.76317591 |
120 | primary alcohol catabolic process (GO:0034310) | 2.74934336 |
121 | * catechol-containing compound metabolic process (GO:0009712) | 2.74451142 |
122 | * catecholamine metabolic process (GO:0006584) | 2.74451142 |
123 | peptide catabolic process (GO:0043171) | 2.72848495 |
124 | protein-lipid complex assembly (GO:0065005) | 2.72506626 |
125 | response to amphetamine (GO:0001975) | 2.72043171 |
126 | multi-organism reproductive behavior (GO:0044705) | 2.71775851 |
127 | * neurotransmitter catabolic process (GO:0042135) | 2.71756901 |
128 | drug transmembrane transport (GO:0006855) | 2.70980351 |
129 | neuron remodeling (GO:0016322) | 2.70429982 |
130 | biotin metabolic process (GO:0006768) | 2.70027489 |
131 | cholesterol homeostasis (GO:0042632) | 2.69886910 |
132 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.69628094 |
133 | complement activation, alternative pathway (GO:0006957) | 2.69327974 |
134 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.69228773 |
135 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.68236260 |
136 | acylglycerol metabolic process (GO:0006639) | 2.68171072 |
137 | plasma lipoprotein particle remodeling (GO:0034369) | 2.66640635 |
138 | protein-lipid complex remodeling (GO:0034368) | 2.66640635 |
139 | macromolecular complex remodeling (GO:0034367) | 2.66640635 |
140 | regulation of cGMP biosynthetic process (GO:0030826) | 2.66262893 |
141 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.66143784 |
142 | sterol homeostasis (GO:0055092) | 2.64787347 |
143 | arginine metabolic process (GO:0006525) | 2.64529228 |
144 | membrane assembly (GO:0071709) | 2.63975434 |
145 | cellular response to nicotine (GO:0071316) | 2.63694909 |
146 | toxin metabolic process (GO:0009404) | 2.63437493 |
147 | neutral lipid metabolic process (GO:0006638) | 2.62993912 |
148 | sulfate transmembrane transport (GO:1902358) | 2.62919676 |
149 | regulation of vitamin metabolic process (GO:0030656) | 2.62233661 |
150 | fatty acid oxidation (GO:0019395) | 2.60961868 |
151 | carnitine transmembrane transport (GO:1902603) | 2.60951176 |
152 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.60244689 |
153 | cholesterol biosynthetic process (GO:0006695) | 2.58933399 |
154 | reproductive behavior (GO:0019098) | 2.58553915 |
155 | monocarboxylic acid catabolic process (GO:0072329) | 2.58459171 |
156 | regulation of guanylate cyclase activity (GO:0031282) | 2.57858111 |
157 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.56895696 |
158 | neuron cell-cell adhesion (GO:0007158) | 2.56418264 |
159 | regulation of vesicle fusion (GO:0031338) | 2.55077181 |
160 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.54399842 |
161 | nucleobase catabolic process (GO:0046113) | 2.53324455 |
162 | intestinal cholesterol absorption (GO:0030299) | 2.53274892 |
163 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.52045048 |
164 | multicellular organismal reproductive behavior (GO:0033057) | 2.50949642 |
165 | response to nicotine (GO:0035094) | 2.47635920 |
166 | electron transport chain (GO:0022900) | 2.46951998 |
167 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.46654930 |
168 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.46654930 |
169 | protein neddylation (GO:0045116) | 2.45871762 |
170 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.41777301 |
171 | response to hepatocyte growth factor (GO:0035728) | 2.41777301 |
172 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.40490423 |
173 | * neurotransmitter transport (GO:0006836) | 2.39025384 |
174 | response to corticosterone (GO:0051412) | 2.38591443 |
175 | response to mineralocorticoid (GO:0051385) | 2.37714442 |
176 | cellular copper ion homeostasis (GO:0006878) | 2.37088438 |
177 | glycine transport (GO:0015816) | 2.36961681 |
178 | negative regulation of neurotransmitter transport (GO:0051589) | 2.36546338 |
179 | regulation of neurotransmitter transport (GO:0051588) | 2.34651970 |
180 | atrial cardiac muscle cell action potential (GO:0086014) | 2.32261464 |
181 | respiratory electron transport chain (GO:0022904) | 2.31800094 |
182 | sterol biosynthetic process (GO:0016126) | 2.31759938 |
183 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.30999527 |
184 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.30788851 |
185 | virion attachment to host cell (GO:0019062) | 2.30763342 |
186 | adhesion of symbiont to host cell (GO:0044650) | 2.30763342 |
187 | monoamine transport (GO:0015844) | 2.30243714 |
188 | adult feeding behavior (GO:0008343) | 2.29685051 |
189 | * neurotransmitter biosynthetic process (GO:0042136) | 2.27141019 |
190 | phospholipid scrambling (GO:0017121) | 2.26656075 |
191 | detection of temperature stimulus (GO:0016048) | 2.26382537 |
192 | regulation of neurotransmitter uptake (GO:0051580) | 2.25729974 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.59459816 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.53922967 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.29902349 |
4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.17559238 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.09732913 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05542099 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.98651711 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.86026554 |
9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.74562200 |
10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.67129228 |
11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58134803 |
12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54431334 |
13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37666275 |
14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.32010005 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.30513621 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30192789 |
17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.28783348 |
18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24213906 |
19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23848005 |
20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.21904223 |
21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.17120883 |
22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.17120883 |
23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.12091806 |
24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09129105 |
25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.08957274 |
26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08418253 |
27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.97316690 |
28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.96833261 |
29 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96267660 |
30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96182803 |
31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96110197 |
32 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.95759914 |
33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94797992 |
34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92992520 |
35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84638593 |
36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.83606712 |
37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.83128230 |
38 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.83109847 |
39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81245242 |
40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76734767 |
41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75011879 |
42 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72074415 |
43 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.72065417 |
44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64070466 |
45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63363489 |
46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.62956626 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60507433 |
48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59071753 |
49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56724316 |
50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.55137181 |
51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.54735597 |
52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54598966 |
53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54391648 |
54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.52950916 |
55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52885772 |
56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51736350 |
57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50375103 |
58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49499642 |
59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48026480 |
60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47131789 |
61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46162609 |
62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44037249 |
63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43785908 |
64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42746662 |
65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42582404 |
66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40889118 |
67 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.40833892 |
68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40139218 |
69 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38550650 |
70 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.37132075 |
71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.36925580 |
72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36324747 |
73 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.35688733 |
74 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33785875 |
75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33591908 |
76 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33292325 |
77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32938038 |
78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32612392 |
79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32117376 |
80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32069312 |
81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31717164 |
82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.31703996 |
83 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.31345199 |
84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31200490 |
85 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31190312 |
86 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27556629 |
87 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27465103 |
88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24939435 |
89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23516851 |
90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.23380049 |
91 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22343411 |
92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21475090 |
93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21307955 |
94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20295795 |
95 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.19530516 |
96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.19530516 |
97 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19377099 |
98 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18891196 |
99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17087044 |
100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16696559 |
101 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16664807 |
102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16200336 |
103 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16142086 |
104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15215644 |
105 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.13711759 |
106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13398524 |
107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13314281 |
108 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13109078 |
109 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13109078 |
110 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12118612 |
111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11982087 |
112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11291025 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10238482 |
114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10117474 |
115 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09436057 |
116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08568224 |
117 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07844196 |
118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07819934 |
119 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06544676 |
120 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04546091 |
121 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04381626 |
122 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03099099 |
123 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02996711 |
124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02024021 |
125 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.01774463 |
126 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01633713 |
127 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00674305 |
128 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98145819 |
129 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97593567 |
130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97572241 |
131 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97305040 |
132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97285619 |
133 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96630132 |
134 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95917936 |
135 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95540964 |
136 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95365911 |
137 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94466514 |
138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94276180 |
139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93897619 |
140 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93586577 |
141 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.92839074 |
142 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92654121 |
143 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92532499 |
144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92184328 |
145 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91944721 |
146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91279058 |
147 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90860015 |
148 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90843695 |
149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90166518 |
150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89845101 |
151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89765211 |
152 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89521685 |
153 | * AR_21909140_ChIP-Seq_LNCAP_Human | 0.89507368 |
154 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89367570 |
155 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.88627707 |
156 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.88345373 |
157 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88261406 |
158 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.84991183 |
159 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84376778 |
160 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83548635 |
161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83219528 |
162 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.81832444 |
163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81625961 |
164 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80699013 |
165 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79061731 |
166 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77461295 |
167 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.77355675 |
168 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.76660934 |
169 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75346688 |
170 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74979435 |
171 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74107159 |
172 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71597901 |
173 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71311422 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.05588727 |
2 | MP0010386_abnormal_urinary_bladder | 4.36725185 |
3 | MP0005365_abnormal_bile_salt | 4.03994062 |
4 | MP0005670_abnormal_white_adipose | 3.78239215 |
5 | MP0002638_abnormal_pupillary_reflex | 3.28925001 |
6 | MP0009379_abnormal_foot_pigmentation | 3.17445867 |
7 | MP0004270_analgesia | 3.04766466 |
8 | MP0000538_abnormal_urinary_bladder | 2.91470845 |
9 | MP0009840_abnormal_foam_cell | 2.87293983 |
10 | MP0004019_abnormal_vitamin_homeostasis | 2.82893249 |
11 | MP0010329_abnormal_lipoprotein_level | 2.68469430 |
12 | MP0005666_abnormal_adipose_tissue | 2.50726769 |
13 | MP0003183_abnormal_peptide_metabolism | 2.41656722 |
14 | MP0006276_abnormal_autonomic_nervous | 2.40444787 |
15 | MP0001529_abnormal_vocalization | 2.37085219 |
16 | MP0002734_abnormal_mechanical_nocicepti | 2.36245648 |
17 | MP0001188_hyperpigmentation | 2.26216939 |
18 | MP0002971_abnormal_brown_adipose | 2.24861330 |
19 | MP0000462_abnormal_digestive_system | 2.14934748 |
20 | MP0002876_abnormal_thyroid_physiology | 2.12245554 |
21 | * MP0001905_abnormal_dopamine_level | 2.04762636 |
22 | MP0005332_abnormal_amino_acid | 2.00402889 |
23 | MP0002822_catalepsy | 10.2968137 |
24 | MP0000372_irregular_coat_pigmentation | 1.91431494 |
25 | MP0005377_hearing/vestibular/ear_phenot | 1.86591229 |
26 | MP0003878_abnormal_ear_physiology | 1.86591229 |
27 | MP0002751_abnormal_autonomic_nervous | 1.83844333 |
28 | MP0009745_abnormal_behavioral_response | 1.83357407 |
29 | MP0002118_abnormal_lipid_homeostasis | 1.82660240 |
30 | * MP0001440_abnormal_grooming_behavior | 1.80866261 |
31 | MP0003283_abnormal_digestive_organ | 1.77186165 |
32 | MP0009643_abnormal_urine_homeostasis | 1.75428156 |
33 | MP0001970_abnormal_pain_threshold | 1.74168255 |
34 | MP0008872_abnormal_physiological_respon | 1.73721818 |
35 | MP0002733_abnormal_thermal_nociception | 1.72760174 |
36 | MP0004782_abnormal_surfactant_physiolog | 1.66092716 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.62636016 |
38 | MP0005375_adipose_tissue_phenotype | 1.61708280 |
39 | MP0005171_absent_coat_pigmentation | 1.58916950 |
40 | MP0003252_abnormal_bile_duct | 1.58862046 |
41 | MP0009384_cardiac_valve_regurgitation | 1.54436715 |
42 | MP0001664_abnormal_digestion | 1.54384119 |
43 | MP0005167_abnormal_blood-brain_barrier | 1.51394658 |
44 | MP0010155_abnormal_intestine_physiology | 1.50201707 |
45 | MP0005409_darkened_coat_color | 1.47482727 |
46 | MP0009115_abnormal_fat_cell | 1.46036832 |
47 | MP0004858_abnormal_nervous_system | 1.45428542 |
48 | MP0005623_abnormal_meninges_morphology | 1.43981044 |
49 | MP0001666_abnormal_nutrient_absorption | 1.43790679 |
50 | MP0010352_gastrointestinal_tract_polyps | 1.40365497 |
51 | MP0003635_abnormal_synaptic_transmissio | 1.40178868 |
52 | MP0004272_abnormal_basement_membrane | 1.37967369 |
53 | MP0005166_decreased_susceptibility_to | 1.36180160 |
54 | MP0001764_abnormal_homeostasis | 1.34506626 |
55 | MP0005636_abnormal_mineral_homeostasis | 1.32560946 |
56 | MP0005535_abnormal_body_temperature | 1.31636694 |
57 | MP0006138_congestive_heart_failure | 1.31175025 |
58 | MP0002064_seizures | 1.30427659 |
59 | MP0005408_hypopigmentation | 1.30406327 |
60 | MP0010234_abnormal_vibrissa_follicle | 1.29860423 |
61 | MP0003879_abnormal_hair_cell | 1.29427261 |
62 | MP0004130_abnormal_muscle_cell | 1.28525182 |
63 | MP0003011_delayed_dark_adaptation | 1.27805662 |
64 | MP0000609_abnormal_liver_physiology | 1.27786601 |
65 | MP0004185_abnormal_adipocyte_glucose | 1.27670226 |
66 | MP0004043_abnormal_pH_regulation | 1.27207267 |
67 | MP0005448_abnormal_energy_balance | 1.25967368 |
68 | MP0001765_abnormal_ion_homeostasis | 1.25192141 |
69 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21338653 |
70 | MP0000778_abnormal_nervous_system | 1.20931782 |
71 | MP0002138_abnormal_hepatobiliary_system | 1.20630050 |
72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19045869 |
73 | MP0005451_abnormal_body_composition | 1.18973884 |
74 | * MP0002572_abnormal_emotion/affect_behav | 1.18846197 |
75 | MP0003866_abnormal_defecation | 1.18585914 |
76 | MP0009780_abnormal_chondrocyte_physiolo | 1.15107653 |
77 | * MP0005386_behavior/neurological_phenoty | 1.13779150 |
78 | * MP0004924_abnormal_behavior | 1.13779150 |
79 | MP0005360_urolithiasis | 1.13587242 |
80 | MP0004859_abnormal_synaptic_plasticity | 1.10764420 |
81 | MP0005334_abnormal_fat_pad | 1.09994957 |
82 | MP0002102_abnormal_ear_morphology | 1.09853880 |
83 | MP0008438_abnormal_cutaneous_collagen | 1.09552943 |
84 | MP0003300_gastrointestinal_ulcer | 1.09113638 |
85 | MP0005381_digestive/alimentary_phenotyp | 1.08732913 |
86 | MP0003880_abnormal_central_pattern | 1.08708136 |
87 | MP0001756_abnormal_urination | 1.07296885 |
88 | MP0003705_abnormal_hypodermis_morpholog | 1.06107642 |
89 | MP0001968_abnormal_touch/_nociception | 1.04610064 |
90 | MP0000537_abnormal_urethra_morphology | 1.03372310 |
91 | MP0002735_abnormal_chemical_nociception | 1.00256032 |
92 | MP0002136_abnormal_kidney_physiology | 0.99290625 |
93 | * MP0002272_abnormal_nervous_system | 0.99272877 |
94 | MP0005197_abnormal_uvea_morphology | 0.98733014 |
95 | MP0008004_abnormal_stomach_pH | 0.97026052 |
96 | MP0003633_abnormal_nervous_system | 0.96083699 |
97 | MP0004147_increased_porphyrin_level | 0.95444313 |
98 | MP0001486_abnormal_startle_reflex | 0.95299516 |
99 | MP0005319_abnormal_enzyme/_coenzyme | 0.94588245 |
100 | MP0005085_abnormal_gallbladder_physiolo | 0.94494384 |
101 | MP0002163_abnormal_gland_morphology | 0.94048796 |
102 | MP0002078_abnormal_glucose_homeostasis | 0.93848095 |
103 | MP0005423_abnormal_somatic_nervous | 0.93391044 |
104 | MP0000230_abnormal_systemic_arterial | 0.92404525 |
105 | MP0005058_abnormal_lysosome_morphology | 0.90429856 |
106 | MP0000604_amyloidosis | 0.88669796 |
107 | MP0001663_abnormal_digestive_system | 0.87469294 |
108 | MP0000762_abnormal_tongue_morphology | 0.87333581 |
109 | MP0003724_increased_susceptibility_to | 0.86843944 |
110 | MP0000477_abnormal_intestine_morphology | 0.86148567 |
111 | MP0009697_abnormal_copulation | 0.85779097 |
112 | * MP0002063_abnormal_learning/memory/cond | 0.85592800 |
113 | MP0002184_abnormal_innervation | 0.85520345 |
114 | MP0003279_aneurysm | 0.84103816 |
115 | MP0003075_altered_response_to | 0.83846525 |
116 | MP0002166_altered_tumor_susceptibility | 0.82467250 |
117 | MP0004742_abnormal_vestibular_system | 0.82159447 |
118 | MP0010678_abnormal_skin_adnexa | 0.81743850 |
119 | MP0003631_nervous_system_phenotype | 0.81398557 |
120 | MP0000566_synostosis | 0.80593259 |
121 | MP0000249_abnormal_blood_vessel | 0.79316537 |
122 | MP0009046_muscle_twitch | 0.78861473 |
123 | MP0008569_lethality_at_weaning | 0.78789716 |
124 | MP0003937_abnormal_limbs/digits/tail_de | 0.78182294 |
125 | MP0005503_abnormal_tendon_morphology | 0.77884720 |
126 | MP0000049_abnormal_middle_ear | 0.76839761 |
127 | MP0000003_abnormal_adipose_tissue | 0.76626294 |
128 | MP0005275_abnormal_skin_tensile | 0.76335417 |
129 | MP0002970_abnormal_white_adipose | 0.76022508 |
130 | MP0003959_abnormal_lean_body | 0.75697241 |
131 | MP0001881_abnormal_mammary_gland | 0.75677185 |
132 | MP0002090_abnormal_vision | 0.75188356 |
133 | MP0003806_abnormal_nucleotide_metabolis | 0.75094717 |
134 | MP0000678_abnormal_parathyroid_gland | 0.74880271 |
135 | MP0009250_abnormal_appendicular_skeleto | 0.73056949 |
136 | MP0010368_abnormal_lymphatic_system | 0.72723366 |
137 | MP0005165_increased_susceptibility_to | 0.72167948 |
138 | MP0003453_abnormal_keratinocyte_physiol | 0.71409086 |
139 | MP0002009_preneoplasia | 0.71233506 |
140 | * MP0003953_abnormal_hormone_level | 0.70706389 |
141 | MP0002127_abnormal_cardiovascular_syste | 0.69502913 |
142 | MP0004215_abnormal_myocardial_fiber | 0.69015635 |
143 | MP0002896_abnormal_bone_mineralization | 0.68713972 |
144 | MP0003868_abnormal_feces_composition | 0.68596412 |
145 | MP0000013_abnormal_adipose_tissue | 0.68235770 |
146 | MP0002909_abnormal_adrenal_gland | 0.67637908 |
147 | * MP0009642_abnormal_blood_homeostasis | 0.67466426 |
148 | MP0003195_calcinosis | 0.67388836 |
149 | MP0005367_renal/urinary_system_phenotyp | 0.66828195 |
150 | MP0000516_abnormal_urinary_system | 0.66828195 |
151 | MP0002736_abnormal_nociception_after | 0.66603940 |
152 | MP0001177_atelectasis | 0.65808703 |
153 | * MP0002557_abnormal_social/conspecific_i | 0.65427105 |
154 | MP0004264_abnormal_extraembryonic_tissu | 0.64706625 |
155 | MP0006072_abnormal_retinal_apoptosis | 0.64295125 |
156 | MP0002098_abnormal_vibrissa_morphology | 0.63069064 |
157 | MP0004947_skin_inflammation | 0.63057643 |
158 | * MP0002067_abnormal_sensory_capabilities | 0.62486296 |
159 | MP0001340_abnormal_eyelid_morphology | 0.62124639 |
160 | MP0003941_abnormal_skin_development | 0.62061630 |
161 | MP0001958_emphysema | 0.61443093 |
162 | MP0003690_abnormal_glial_cell | 0.61169423 |
163 | MP0000383_abnormal_hair_follicle | 0.60566085 |
164 | MP0004484_altered_response_of | 0.60299368 |
165 | * MP0002882_abnormal_neuron_morphology | 0.58985526 |
166 | MP0005379_endocrine/exocrine_gland_phen | 0.58890205 |
167 | MP0000467_abnormal_esophagus_morphology | 0.58480952 |
168 | MP0002796_impaired_skin_barrier | 0.57962470 |
169 | MP0005647_abnormal_sex_gland | 0.57401915 |
170 | * MP0002066_abnormal_motor_capabilities/c | 0.56941314 |
171 | MP0002160_abnormal_reproductive_system | 0.56790298 |
172 | MP0001963_abnormal_hearing_physiology | 0.56776934 |
173 | MP0003136_yellow_coat_color | 0.56589054 |
174 | MP0002752_abnormal_somatic_nervous | 0.55855886 |
175 | MP0002233_abnormal_nose_morphology | 0.55534903 |
176 | MP0005551_abnormal_eye_electrophysiolog | 0.54703889 |
177 | MP0003385_abnormal_body_wall | 0.53321177 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Orthostatic hypotension (HP:0001278) | 6.38225117 |
2 | Abnormal autonomic nervous system physiology (HP:0012332) | 5.41109134 |
3 | Hydroxyprolinuria (HP:0003080) | 4.86454014 |
4 | Abnormality of proline metabolism (HP:0010907) | 4.86454014 |
5 | Malnutrition (HP:0004395) | 4.82264554 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.80781080 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.77507261 |
8 | Myokymia (HP:0002411) | 4.61114423 |
9 | Neonatal hypoglycemia (HP:0001998) | 4.57684326 |
10 | Complement deficiency (HP:0004431) | 4.56538188 |
11 | Fat malabsorption (HP:0002630) | 4.42527640 |
12 | Ileus (HP:0002595) | 4.35539963 |
13 | Hypobetalipoproteinemia (HP:0003563) | 4.17965139 |
14 | Limb dystonia (HP:0002451) | 4.04407023 |
15 | Abnormality of complement system (HP:0005339) | 3.86322571 |
16 | Exotropia (HP:0000577) | 3.72193449 |
17 | Xanthomatosis (HP:0000991) | 3.70880290 |
18 | Glomerulonephritis (HP:0000099) | 3.39901237 |
19 | Autoamputation (HP:0001218) | 3.37985489 |
20 | Hypotension (HP:0002615) | 3.32738320 |
21 | Decreased circulating renin level (HP:0003351) | 3.28746962 |
22 | Widely patent fontanelles and sutures (HP:0004492) | 3.27479649 |
23 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.26978543 |
24 | Sensory axonal neuropathy (HP:0003390) | 3.25108452 |
25 | Amblyopia (HP:0000646) | 3.22864535 |
26 | Steatorrhea (HP:0002570) | 3.16244072 |
27 | Abnormality of vitamin metabolism (HP:0100508) | 3.06535690 |
28 | Pigmentary retinal degeneration (HP:0001146) | 3.05548349 |
29 | Hemorrhage of the eye (HP:0011885) | 3.02632542 |
30 | Hyperammonemia (HP:0001987) | 3.02600506 |
31 | Intrahepatic cholestasis (HP:0001406) | 3.00201306 |
32 | Hyperglycinuria (HP:0003108) | 2.98235703 |
33 | Nausea (HP:0002018) | 2.97062753 |
34 | Chronic diarrhea (HP:0002028) | 2.94944212 |
35 | Epidermoid cyst (HP:0200040) | 2.93123545 |
36 | Metabolic alkalosis (HP:0200114) | 2.81980064 |
37 | Proximal tubulopathy (HP:0000114) | 2.80544160 |
38 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.79179103 |
39 | Thin bony cortex (HP:0002753) | 2.76291287 |
40 | Termporal pattern (HP:0011008) | 2.72980358 |
41 | Insidious onset (HP:0003587) | 2.72980358 |
42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.72868434 |
43 | Abnormality of vitamin B metabolism (HP:0004340) | 2.72244567 |
44 | Hypolipoproteinemia (HP:0010981) | 2.66385635 |
45 | Acanthocytosis (HP:0001927) | 2.65734310 |
46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.62764379 |
47 | Abnormality of glycine metabolism (HP:0010895) | 2.62764379 |
48 | Nephritis (HP:0000123) | 2.58221302 |
49 | Hypoventilation (HP:0002791) | 2.58155446 |
50 | Alkalosis (HP:0001948) | 2.57199420 |
51 | Cupped ribs (HP:0000887) | 2.51429131 |
52 | Glycosuria (HP:0003076) | 2.49939065 |
53 | Abnormality of urine glucose concentration (HP:0011016) | 2.49939065 |
54 | Fragile skin (HP:0001030) | 2.49911949 |
55 | Abnormality of the corticospinal tract (HP:0002492) | 2.49858950 |
56 | Skin nodule (HP:0200036) | 2.49237578 |
57 | Acute necrotizing encephalopathy (HP:0006965) | 2.48878660 |
58 | Atonic seizures (HP:0010819) | 2.48140901 |
59 | Action tremor (HP:0002345) | 2.47781188 |
60 | Confusion (HP:0001289) | 2.46715076 |
61 | Wide cranial sutures (HP:0010537) | 2.44825335 |
62 | Short hallux (HP:0010109) | 2.41060234 |
63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.40540928 |
64 | Abnormal pupillary function (HP:0007686) | 2.37023161 |
65 | Hyperlipoproteinemia (HP:0010980) | 2.34793575 |
66 | Focal segmental glomerulosclerosis (HP:0000097) | 2.34748303 |
67 | Ulnar claw (HP:0001178) | 2.33691276 |
68 | Abnormality of the 2nd finger (HP:0004100) | 2.33559534 |
69 | Recurrent corneal erosions (HP:0000495) | 2.33378466 |
70 | Hyperthyroidism (HP:0000836) | 2.32189942 |
71 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.32049148 |
72 | Deep venous thrombosis (HP:0002625) | 2.30382925 |
73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.27568188 |
74 | Focal motor seizures (HP:0011153) | 2.27063740 |
75 | Abnormality of the 1st metacarpal (HP:0010009) | 2.26328399 |
76 | Bradycardia (HP:0001662) | 2.25577851 |
77 | Focal seizures (HP:0007359) | 2.25494559 |
78 | Progressive macrocephaly (HP:0004481) | 2.25395438 |
79 | Aplasia of the phalanges of the hand (HP:0009802) | 2.23833735 |
80 | Aplasia involving bones of the extremities (HP:0009825) | 2.23833735 |
81 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.23833735 |
82 | Abnormality of purine metabolism (HP:0004352) | 2.22118764 |
83 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.21647653 |
84 | Overfolded helix (HP:0000396) | 2.21025617 |
85 | Growth hormone excess (HP:0000845) | 2.20135484 |
86 | Nephrolithiasis (HP:0000787) | 2.19157081 |
87 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.18848041 |
88 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.18848041 |
89 | Hypophosphatemia (HP:0002148) | 2.17358304 |
90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.16311499 |
91 | Microglossia (HP:0000171) | 2.15795121 |
92 | Hyperuricemia (HP:0002149) | 2.15262356 |
93 | Increased purine levels (HP:0004368) | 2.15262356 |
94 | Abnormal glucose tolerance (HP:0001952) | 2.14374386 |
95 | Right ventricular cardiomyopathy (HP:0011663) | 2.13223432 |
96 | Axonal loss (HP:0003447) | 2.12476246 |
97 | Progressive cerebellar ataxia (HP:0002073) | 2.12402599 |
98 | Abnormally folded helix (HP:0008544) | 2.11751194 |
99 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.09589486 |
100 | Rickets (HP:0002748) | 2.08285418 |
101 | Renal tubular acidosis (HP:0001947) | 2.07582059 |
102 | Vascular calcification (HP:0004934) | 2.07429786 |
103 | Metabolic acidosis (HP:0001942) | 2.06932860 |
104 | Short tibia (HP:0005736) | 2.05464948 |
105 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.05164815 |
106 | Acanthosis nigricans (HP:0000956) | 2.04141660 |
107 | Aplasia cutis congenita (HP:0001057) | 2.03036540 |
108 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.02303211 |
109 | Hyperaldosteronism (HP:0000859) | 2.02139834 |
110 | Hypothermia (HP:0002045) | 11.0592094 |
111 | Congenital sensorineural hearing impairment (HP:0008527) | 1.99892657 |
112 | Pancreatitis (HP:0001733) | 1.98844388 |
113 | Hypertriglyceridemia (HP:0002155) | 1.97512330 |
114 | Generalized aminoaciduria (HP:0002909) | 1.97510090 |
115 | Abnormality of carpal bone ossification (HP:0006257) | 1.97352359 |
116 | Subcapsular cataract (HP:0000523) | 1.97161053 |
117 | Rhabdomyolysis (HP:0003201) | 1.96533690 |
118 | Hypercholesterolemia (HP:0003124) | 1.95291977 |
119 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.94813903 |
120 | Abnormality of nucleobase metabolism (HP:0010932) | 1.94030222 |
121 | Abnormality of chloride homeostasis (HP:0011422) | 1.93878317 |
122 | Glomerulosclerosis (HP:0000096) | 1.92563553 |
123 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.91923408 |
124 | Enlarged epiphyses (HP:0010580) | 1.91736196 |
125 | Pheochromocytoma (HP:0002666) | 1.91082676 |
126 | Neonatal short-limb short stature (HP:0008921) | 1.91039992 |
127 | Hypoglycemic coma (HP:0001325) | 1.90994163 |
128 | Cerebral inclusion bodies (HP:0100314) | 1.90896504 |
129 | Cardiovascular calcification (HP:0011915) | 1.90881109 |
130 | Myotonia (HP:0002486) | 1.90566645 |
131 | Atrophic scars (HP:0001075) | 1.90549668 |
132 | Broad metatarsal (HP:0001783) | 1.89409108 |
133 | External ophthalmoplegia (HP:0000544) | 1.88263861 |
134 | Bone cyst (HP:0012062) | 1.87967422 |
135 | Xerostomia (HP:0000217) | 1.86962661 |
136 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.86619832 |
137 | Hyperparathyroidism (HP:0000843) | 1.85786959 |
138 | Flat acetabular roof (HP:0003180) | 1.85676133 |
139 | Postural tremor (HP:0002174) | 1.84563277 |
140 | Spinal cord compression (HP:0002176) | 1.83634051 |
141 | Acute encephalopathy (HP:0006846) | 1.82640586 |
142 | Stenosis of the external auditory canal (HP:0000402) | 1.82623011 |
143 | Tetraparesis (HP:0002273) | 1.82368419 |
144 | Dicarboxylic aciduria (HP:0003215) | 1.81983821 |
145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81983821 |
146 | Facial shape deformation (HP:0011334) | 1.81531369 |
147 | Potter facies (HP:0002009) | 1.81531369 |
148 | Protuberant abdomen (HP:0001538) | 1.80413360 |
149 | Myocardial infarction (HP:0001658) | 1.79661570 |
150 | Delayed epiphyseal ossification (HP:0002663) | 1.79651056 |
151 | Neurofibrillary tangles (HP:0002185) | 1.78266468 |
152 | Distal lower limb amyotrophy (HP:0008944) | 1.77194168 |
153 | Visceral angiomatosis (HP:0100761) | 1.76392429 |
154 | Glossoptosis (HP:0000162) | 1.76004638 |
155 | Myoglobinuria (HP:0002913) | 1.74790239 |
156 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.74659805 |
157 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.74432404 |
158 | Anhidrosis (HP:0000970) | 1.71551405 |
159 | Mitochondrial inheritance (HP:0001427) | 1.71448859 |
160 | Oligomenorrhea (HP:0000876) | 1.70689323 |
161 | Cerebral palsy (HP:0100021) | 1.69895539 |
162 | Optic disc pallor (HP:0000543) | 1.67465861 |
163 | Irritability (HP:0000737) | 1.67120061 |
164 | Syncope (HP:0001279) | 1.66889860 |
165 | Abnormality of the costochondral junction (HP:0000919) | 1.66615190 |
166 | Parakeratosis (HP:0001036) | 1.66050107 |
167 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.65515831 |
168 | Septate vagina (HP:0001153) | 1.64885349 |
169 | Gastrointestinal dysmotility (HP:0002579) | 1.64415485 |
170 | Increased hepatocellular lipid droplets (HP:0006565) | 1.64339750 |
171 | Relative macrocephaly (HP:0004482) | 1.63057875 |
172 | Onycholysis (HP:0001806) | 1.61210994 |
173 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60486681 |
174 | Generalized tonic-clonic seizures (HP:0002069) | 1.60039475 |
175 | Agitation (HP:0000713) | 1.59496925 |
176 | Metaphyseal dysplasia (HP:0100255) | 1.59455239 |
177 | Diminished movement (HP:0002374) | 1.58164438 |
178 | Neuroendocrine neoplasm (HP:0100634) | 1.56956301 |
179 | Upper limb muscle weakness (HP:0003484) | 1.55257798 |
180 | Prolonged QT interval (HP:0001657) | 1.54778186 |
181 | Hyperactive renin-angiotensin system (HP:0000841) | 1.54019271 |
182 | Hemiparesis (HP:0001269) | 1.53317407 |
183 | Abdominal distention (HP:0003270) | 1.53150260 |
184 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.52726124 |
185 | Short phalanx of the thumb (HP:0009660) | 1.51919684 |
186 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.51823110 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK1 | 4.40986780 |
2 | ACVR1B | 4.32931115 |
3 | GRK7 | 3.56661513 |
4 | ERN1 | 3.38317643 |
5 | EPHA2 | 2.88152351 |
6 | FRK | 2.87653161 |
7 | MST1R | 2.73737143 |
8 | LMTK2 | 2.57182339 |
9 | MST4 | 2.51005520 |
10 | MAPKAPK5 | 2.50441610 |
11 | MATK | 2.47450723 |
12 | STK39 | 2.24398970 |
13 | GRK5 | 2.20917337 |
14 | PRKD3 | 2.17546130 |
15 | EPHA3 | 2.10267549 |
16 | CASK | 2.02374272 |
17 | TRIB3 | 2.01673526 |
18 | LIMK1 | 1.94883896 |
19 | MET | 1.93393748 |
20 | PIK3CA | 1.83055022 |
21 | DDR2 | 1.82428440 |
22 | EPHB2 | 1.71632308 |
23 | MAP3K4 | 1.71625783 |
24 | MYLK | 1.69876930 |
25 | MAP3K12 | 1.69515108 |
26 | NME1 | 1.69355579 |
27 | MAP2K1 | 1.64978256 |
28 | PNCK | 1.64922567 |
29 | FGFR4 | 1.64007531 |
30 | PRKG2 | 1.61930445 |
31 | MAP2K2 | 1.54372167 |
32 | NTRK3 | 1.52003040 |
33 | EPHB1 | 1.47135893 |
34 | EEF2K | 1.40807956 |
35 | TESK1 | 1.39780097 |
36 | CSNK1G3 | 1.38274380 |
37 | FGR | 1.34917380 |
38 | MAP3K2 | 1.33962747 |
39 | PRKCE | 1.32221210 |
40 | STK24 | 1.29160327 |
41 | OXSR1 | 1.28486792 |
42 | ADRBK1 | 1.28166389 |
43 | GRK6 | 1.28089816 |
44 | PDK2 | 1.26371691 |
45 | CAMK2B | 1.26098747 |
46 | CSNK1G2 | 1.24598230 |
47 | PTK6 | 1.22319694 |
48 | CAMK2D | 1.21260780 |
49 | WNK1 | 1.19748549 |
50 | TGFBR2 | 1.18674908 |
51 | FGFR3 | 1.16070907 |
52 | CAMK1D | 1.15015662 |
53 | SIK1 | 1.14975229 |
54 | PDPK1 | 1.14296369 |
55 | NLK | 1.11654420 |
56 | ICK | 1.11617729 |
57 | CSNK1G1 | 1.11263148 |
58 | TIE1 | 1.10592043 |
59 | MAPKAPK3 | 1.10498805 |
60 | AKT3 | 1.10291908 |
61 | DMPK | 1.10032620 |
62 | ARAF | 1.08480723 |
63 | MARK1 | 1.08457024 |
64 | PAK3 | 1.07091290 |
65 | MAP3K3 | 1.06744882 |
66 | NTRK2 | 1.05341889 |
67 | INSRR | 1.05249962 |
68 | PBK | 1.04744561 |
69 | NEK9 | 1.04518095 |
70 | CDC42BPA | 1.04300701 |
71 | GRK1 | 1.03237068 |
72 | WNK4 | 1.01644571 |
73 | PTK2B | 1.01203011 |
74 | MINK1 | 0.99483858 |
75 | PRPF4B | 0.97927584 |
76 | FER | 0.95825256 |
77 | TNIK | 0.95448208 |
78 | BCR | 0.94916536 |
79 | CAMK2G | 0.93424738 |
80 | MAP3K1 | 0.93160689 |
81 | TYK2 | 0.91100433 |
82 | MAP2K7 | 0.90752993 |
83 | ERBB2 | 0.88104332 |
84 | RET | 0.87617087 |
85 | PKN2 | 0.85812623 |
86 | CAMK2A | 0.83704391 |
87 | ERBB4 | 0.82328938 |
88 | ABL2 | 0.82106964 |
89 | BMPR1B | 0.81003116 |
90 | UHMK1 | 0.79171786 |
91 | PTK2 | 0.79021021 |
92 | PLK2 | 0.78865909 |
93 | KSR2 | 0.78172831 |
94 | MAP3K9 | 0.76617400 |
95 | JAK1 | 0.76410001 |
96 | PRKACG | 0.75504244 |
97 | CDK15 | 0.72369574 |
98 | CDK14 | 0.72044612 |
99 | CDK6 | 0.71628681 |
100 | ROCK2 | 0.71602979 |
101 | TRPM7 | 0.70745586 |
102 | CDK18 | 0.69748899 |
103 | CDK5 | 0.69621954 |
104 | PDK1 | 0.67581897 |
105 | STK11 | 0.67051157 |
106 | SGK3 | 0.67006784 |
107 | SGK2 | 0.66546707 |
108 | PDGFRB | 0.64575273 |
109 | SGK223 | 0.62684141 |
110 | SGK494 | 0.62684141 |
111 | CDK11A | 0.62282594 |
112 | ROCK1 | 0.61867928 |
113 | EPHA4 | 0.61386131 |
114 | MUSK | 0.59598835 |
115 | LATS2 | 0.59270935 |
116 | MAP3K6 | 0.58499208 |
117 | PRKD2 | 0.58444664 |
118 | MAPK13 | 0.58002879 |
119 | MAP3K10 | 0.57727110 |
120 | PDGFRA | 0.55382593 |
121 | MAP2K4 | 0.55319675 |
122 | PRKAA1 | 0.55056414 |
123 | PAK2 | 0.54434542 |
124 | MAP2K6 | 0.54247653 |
125 | CAMKK2 | 0.53823055 |
126 | CSNK1A1L | 0.53122614 |
127 | PRKAA2 | 0.52630055 |
128 | PRKG1 | 0.52032425 |
129 | RPS6KA2 | 0.51270420 |
130 | LATS1 | 0.50246666 |
131 | PHKG2 | 0.49118815 |
132 | PHKG1 | 0.49118815 |
133 | DAPK2 | 0.48898831 |
134 | RIPK1 | 0.48839884 |
135 | SRC | 0.48688026 |
136 | GSK3A | 0.48210658 |
137 | PRKD1 | 0.47789184 |
138 | JAK2 | 0.47589411 |
139 | YES1 | 0.47521310 |
140 | CSNK1E | 0.45653269 |
141 | PRKCZ | 0.45227635 |
142 | PRKCI | 0.44144215 |
143 | CAMK1G | 0.43191535 |
144 | PKN1 | 0.42343112 |
145 | TYRO3 | 0.41348447 |
146 | IRAK3 | 0.40931561 |
147 | IRAK1 | 0.40534015 |
148 | IGF1R | 0.39489239 |
149 | DYRK2 | 0.39425224 |
150 | TAOK1 | 0.39394641 |
151 | DAPK3 | 0.38832816 |
152 | PRKACA | 0.38485337 |
153 | TBK1 | 0.38167615 |
154 | INSR | 0.37986129 |
155 | MAPK11 | 0.37971165 |
156 | ILK | 0.37596228 |
157 | FYN | 0.37525086 |
158 | PAK4 | 0.37477637 |
159 | MAPK4 | 0.35008509 |
160 | PRKCA | 0.33513924 |
161 | MAPK12 | 0.32943548 |
162 | MAPK7 | 0.30959788 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.98812195 |
2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.39394337 |
3 | Mineral absorption_Homo sapiens_hsa04978 | 3.12638260 |
4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.84040974 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78125212 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.73375122 |
7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.69693719 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40517682 |
9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39687520 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.35509516 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35281526 |
12 | Retinol metabolism_Homo sapiens_hsa00830 | 2.21078611 |
13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14258494 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.06321849 |
15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.00907758 |
16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.98901592 |
17 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 1.96379912 |
18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.94119230 |
19 | Bile secretion_Homo sapiens_hsa04976 | 1.77844517 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74715934 |
21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.74066229 |
22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.70414920 |
23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66903962 |
24 | * Serotonergic synapse_Homo sapiens_hsa04726 | 1.62029984 |
25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.61821258 |
26 | Salivary secretion_Homo sapiens_hsa04970 | 1.61687840 |
27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.56490449 |
28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.53835362 |
29 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.49458121 |
30 | Renin secretion_Homo sapiens_hsa04924 | 1.47563701 |
31 | * Cocaine addiction_Homo sapiens_hsa05030 | 1.47545455 |
32 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46515421 |
33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46104729 |
34 | Long-term depression_Homo sapiens_hsa04730 | 1.45640491 |
35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.44437350 |
36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43520089 |
37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.35232878 |
38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31841353 |
39 | Gap junction_Homo sapiens_hsa04540 | 1.31746227 |
40 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30000299 |
41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27380146 |
42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.26884508 |
43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.26852705 |
44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.24655711 |
45 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.24479361 |
46 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 1.23889184 |
47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21478175 |
48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21477328 |
49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21448052 |
50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.20779229 |
51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20496268 |
52 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.20474764 |
53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19755730 |
54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.19261035 |
55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18975554 |
56 | Axon guidance_Homo sapiens_hsa04360 | 1.18444789 |
57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17643187 |
58 | * Amphetamine addiction_Homo sapiens_hsa05031 | 1.15525191 |
59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15508818 |
60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.15019393 |
61 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14862728 |
62 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11830458 |
63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11447246 |
64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11432292 |
65 | Nicotine addiction_Homo sapiens_hsa05033 | 1.11376302 |
66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.09585595 |
67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08548250 |
68 | Tight junction_Homo sapiens_hsa04530 | 1.07166599 |
69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.06380384 |
70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03775814 |
71 | Insulin secretion_Homo sapiens_hsa04911 | 1.03765170 |
72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03344501 |
73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02061054 |
74 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99187316 |
75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99043678 |
76 | Taste transduction_Homo sapiens_hsa04742 | 0.98670803 |
77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98666973 |
78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95514065 |
79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95135788 |
80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94405277 |
81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93849723 |
82 | Peroxisome_Homo sapiens_hsa04146 | 0.91982545 |
83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88799426 |
84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88494525 |
85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83103699 |
86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82162401 |
87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81586033 |
88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77378816 |
89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76898535 |
90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.76169223 |
91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76012379 |
92 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75982414 |
93 | Melanogenesis_Homo sapiens_hsa04916 | 0.75870521 |
94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71523960 |
95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70580655 |
96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69964551 |
97 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69216121 |
98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68731862 |
99 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68531901 |
100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68171538 |
101 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65677928 |
102 | Insulin resistance_Homo sapiens_hsa04931 | 0.65038919 |
103 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65015866 |
104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64772758 |
105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64135612 |
106 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63523762 |
107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62208262 |
108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61874504 |
109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60881310 |
110 | ABC transporters_Homo sapiens_hsa02010 | 0.60649448 |
111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60269604 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59343563 |
113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58145209 |
114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56851678 |
115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56383957 |
116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55766539 |
117 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55495842 |
118 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55102924 |
119 | Morphine addiction_Homo sapiens_hsa05032 | 0.53986202 |
120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.53342794 |
121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52642806 |
122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51915216 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51618347 |
124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50684031 |
125 | Prion diseases_Homo sapiens_hsa05020 | 0.49313260 |
126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49140487 |
127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49104601 |
128 | * Alcoholism_Homo sapiens_hsa05034 | 0.48950098 |
129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46705961 |
130 | * Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44317807 |
131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43613972 |
132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42460423 |
133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42428859 |
134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42387122 |
135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41590861 |
136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41348004 |
137 | Phototransduction_Homo sapiens_hsa04744 | 0.40391503 |
138 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40296759 |
139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38413531 |
140 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38337772 |
141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38316682 |
142 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37336728 |
143 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37264208 |
144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36318214 |
145 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29265539 |
146 | Pertussis_Homo sapiens_hsa05133 | 0.28248325 |
147 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27582068 |
148 | Amoebiasis_Homo sapiens_hsa05146 | 0.24148423 |
149 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.22065322 |
150 | Hepatitis C_Homo sapiens_hsa05160 | 0.19869377 |
151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16786265 |
152 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16327441 |
153 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.07704543 |
154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.03039745 |
155 | Lysine degradation_Homo sapiens_hsa00310 | 0.02400138 |